News

Here’s a look back at selections from our March content series on mood disorders.

"The diameter of the bomb was thirty centimeters and the diameter of its effective range about seven meters, with four dead and eleven wounded."

Tomorrow is National Doctors’ Day!

Our March CME reviews the principles and applications of invasive and noninvasive neuromodulation techniques for the treatment of mood disorders. Here are 5 key takeaways.

Palestinian children in the Gaza Strip experience complex continuous trauma.

Courageous leadership is relevant for any stage of an organization or individual patient encountering crisis and the choice of multiple options of how to proceed.

This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.

Here's why it's important to take your time...

The short-acting psychedelic, BPL-003, resulted in rapid, durable depression symptom reduction in patients with TRD.

What is the Clubhouse model of psychosocial rehabilitation, and how can it benefit both patients and clinicians alike?

Some of the most divisive notions in the Western world and the Global North: individualism and independence. Are they a myth?

Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.

The world would benefit from the values and knowledge of Indigenous individuals, who have been displaced and colonized.

“Our patients, our field, and our integrity demand a better explanation of what happened in STAR*D than what has thus been provided.”

A convergence of religion and spring… What does it mean for our mental health?

From the relationship between glucose fluctuations and cognition in patients with type 1 diabetes to augmentation strategies for treatment-resistant depression, here are highlights from the week in Psychiatric Times.

What is new in research on COVID-19?

Empowerment has a significant correlation with patients’ overall mental and physical well-being, and has been central to the shift in conceptual framework of mental illness recovery towards a focus on resilience, strength, and control over one’s life.

"The buttonholes, the sizing, the facing, the characters. Printed in black on neckband and tail. The shape, the label, the labor, the color, the shade. The shirt."

This may be a pivotal moment in the history of psychedelics...

In this CME article, review the principles and applications of both invasive and noninvasive neuromodulation techniques for the treatment of mood disorders.

The trial aims to investigate the positive, negative, and cognitive domains of schizophrenia.

How can we fix our loneliness problem?

It has been 4 years of COVID-19. Are we in a better spot now than we were then?

"...seeking and longing for the garden of cherry blossoms..."

Here's how embracing a comprehensive, patient-centered approach and staying informed about emerging treatments can help mental health professionals make a difference in the lives of patients with TRD.

Welcome to the new column, “Second Thoughts… About Psychiatry, Psychology, and Psychotherapy.”

What is spring mania, and what are some effective clinical strategies for addressing it?

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.